RedHill Biopharma Ltd. (RDHL)

6.89
0.04 0.58
NASDAQ : Health Technology
Prev Close 6.85
Open 6.94
Day Low/High 6.66 / 6.94
52 Wk Low/High 4.40 / 11.49
Volume 52.14K
Avg Volume 111.00K
Exchange NASDAQ
Shares Outstanding 28.37M
Market Cap 198.45M
EPS -2.60
P/E Ratio 26.35
Div & Yield N.A. (N.A)

Latest News

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

TheStreet Quant Rating: D- (Sell)